|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
National Institute of Mental Health (NIMH) |
| Information provided by: | National Institute of Mental Health (NIMH) |
| ClinicalTrials.gov Identifier: | NCT00078728 |
Purpose
This study will evaluate the effectiveness of a short-term family-based program for preventing anxiety disorders in at-risk children.
| Condition | Intervention |
|
Anxiety Disorders |
Behavioral: Family-Based Anxiety Prevention Program |
| MedlinePlus related topics: | Anxiety |
| Study Type: | Interventional |
| Study Design: | Prevention, Randomized, Open Label, Placebo Control, Parallel Assignment, Efficacy Study |
| Official Title: | Family-Based Prevention for Childhood Anxiety |
| Estimated Enrollment: | 40 |
| Study Start Date: | September 2003 |
| Estimated Study Completion Date: | December 2005 |
Anxiety disorder is a serious condition that can negatively impact a person's overall functioning. This study will enroll mothers with anxiety disorders and their children to determine whether a brief family-based intervention will reduce childhood anxiety better than standard care.
Participants will be randomly assigned to either the family-based prevention program or to evaluation only for 8 weeks. Participants in the prevention program will have weekly sessions with a therapist and will learn skills to help reduce anxiety. Self- and parent-reports, diagnostic interviews, a computerized memory task, and a videotaped parent-child interaction task will be used to assess participants. Assessments will be conducted at study start and one week after study completion (Week 9). Follow-up visits will be conducted at 6 and 12 months after study completion.
Eligibility
| Ages Eligible for Study: | 7 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Contacts and Locations| United States, Maryland | |||||
| Johns Hopkins University School of Medicine | |||||
| Baltimore, Maryland, United States, 21205 | |||||
| Principal Investigator: | Golda S. Ginsburg, PhD | Johns Hopkins University |
More Information
| Study ID Numbers: | K23 MH63427, DDTR BK-TKPD |
| First Received: | March 5, 2004 |
| Last Updated: | October 23, 2007 |
| ClinicalTrials.gov Identifier: | NCT00078728 |
| Health Authority: | United States: Federal Government |
|
|